NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
October 1, 2025 — Sapu Nano receives HREC approval for Sapu003 clinical trials in Australia. The injectable cancer treatment uses Deciparticle technology to enhance Everolimus delivery for breast cancer patients.
October 1, 2025 — Soligenix closes $7.5M public offering to fund rare disease treatments including HyBryte for CTCL and vaccine candidates. Funding extends cash runway through 2026 for clinical development.
October 1, 2025 — Quantum BioPharma appoints MS expert Dr. Jack Antel to advance Lucid-MS Phase 2 trials. Learn about this innovative multiple sclerosis treatment targeting myelin repair.
October 1, 2025 — Hoth Therapeutics partners with Lantern Pharma to use AI platform PredictBBB.ai for drug development. Technology predicts blood-brain barrier penetration with 94% accuracy.
October 1, 2025 — American Heart Association acquires Cardiometabolic Center Alliance to advance integrated cardiovascular, kidney & metabolic care. Strategic partnership combines proven care models for better patient outcomes.
October 1, 2025 — GeoVax sponsors 2025 Global Health Equity Summit, showcasing MVA-based vaccines for underserved populations. Learn about their commitment to equitable vaccine access and innovative healthcare solutions.
October 1, 2025 — NYU's Dr. Judith Hochman receives 2025 American Heart Association Research Achievement Award for groundbreaking cardiovascular trials that transformed global clinical guidelines and improved patient outcomes.
October 1, 2025 — Davis, Saperstein & Salomon launches #EmployersThinkPink, offering paid time off for mammograms during Breast Cancer Awareness Month to promote early detection.
October 1, 2025 — Medicaid faces severe threats that could leave 89 million Americans vulnerable. Dr. Susan Reynolds warns of devastating cuts to rural hospitals and coverage losses impacting communities nationwide.
October 1, 2025 — Lauderdale County jury awards $7M to dentist Sunitha Madasu in medical malpractice case against Dr. Donald Bowling and Lauderdale Radiology for missed brain clot diagnosis.
October 1, 2025 — National survey reveals 48% of Americans suffer unexplained pain. Neuroplastic symptoms cost healthcare more than cancer & heart disease combined. Effective treatments exist but awareness remains low.
September 30, 2025 — Lantern Pharma receives FDA guidance for pediatric brain cancer therapy LP-184/STAR-001, plans 2026 trial launch. Company advancing multiple cancer treatments using computational biology platform.
September 30, 2025 — Fifty 1 Labs acquires BioSpark AI Technologies, gaining patented AI systems for clinical data analysis and LLM ensemble technology to advance AI-powered healthcare solutions and drug discovery.
September 30, 2025 — Scorpion venom shows promise in treating aggressive brain cancer. Researchers at City of Hope and CNS Pharmaceuticals are developing new therapies using chlorotoxin from scorpion venom to target glioblastoma tumors.
September 30, 2025 — Tonix Pharmaceuticals receives FDA clearance for Phase 2 trial of TNX-2900 for Prader-Willi syndrome, a rare genetic disorder causing childhood obesity with Orphan Drug designation.
September 30, 2025 — Soligenix expands European Medical Advisory Board for HyBryte™ Phase 3 trial in cutaneous T-cell lymphoma. Late-stage biopharma company advances novel photodynamic therapy.
September 30, 2025 — Branded Legacy files patent for innovative air-powered intranasal drug delivery device designed for precise dosing of medications including naloxone and unstable formulations requiring reconstitution.
September 30, 2025 — GeoVax Labs raises $2.5M to advance COVID-19 vaccines for immunocompromised patients and cancer immunotherapies. Funding supports Phase 2 trials and novel treatments.
September 30, 2025 — ArcticCollagen's marine collagen supplement combines 8,000mg collagen, hyaluronic acid & vitamin C. Backed by science, improves skin elasticity & hydration. Available on Amazon & major retailers.
September 30, 2025 — Doctorpresso unveils Therapods AI therapy earbuds at CES 2026. World's first AI-powered earbuds for virtual group therapy with real-time emotion sensing at lower costs.